References
- Liu J, Fang G, Lan C, et al. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling. Drug Des Devel Ther. 2024;18:767–780. doi:10.2147/DDDT.S444605
- Xia M, Zhang Y, Wu H, et al. Forsythoside B attenuates neuro-inflammation and neuronal apoptosis by inhibition of NF-κB and p38-MAPK signaling pathways through activating Nrf2 post spinal cord injury. Int Immunopharmacol. 2022;111:109120. doi:10.1016/j.intimp.2022.109120
- Jasenovec T, Radosinska D, Kollarova M, et al. Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats: focus on Plasma and Erythrocyte Parameters. Pharmaceuticals. 2022;15(10):1227. doi:10.3390/ph15101227
- Matsumori A. Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease. Eur Cardiol Rev. 2023;18:e40. doi:10.15420/ecr.2023.10
- Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review). Int J Mol Med. 2022;49(2):15. doi:10.3892/ijmm.2021.5070